Alpha Cognition — Alzheimer's/CNS therapeutics
| Filed | Insider | Role | Shares | Value | |
|---|---|---|---|---|---|
| 2026-07-24 | Opaleye Management Inc. | 10%-owner | 200,086 | $1,565,500 | Form 4 |
| 2026-06-29 | Opaleye Management Inc. | 10%-owner | 152,533 | $976,490 | Form 4 |
| 2026-05-29 | Opaleye Management Inc. | 10%-owner | 73,738 | $434,714 | Form 4 |
| 2026-03-06 | Opaleye Management Inc. | 10%-owner | 66,818 | $387,742 | Form 4 |
| 2026-03-04 | Opaleye Management Inc. | 10%-owner | 71,411 | $411,613 | Form 4 |
| 2026-02-24 | Opaleye Management Inc. | 10%-owner | 171,410 | $1,003,691 | Form 4 |
| Report | Date | Stance |
|---|---|---|
| #97 — Rough Seas Make Strong Sailors: Navigating the Healthcare Policy Tsunami | 2025-05-28 | LONG |
from2028 — cross-site stock view. Rebuilt at publish time.